Substance / Medication

Mequinol

Overview

Active Ingredient
mequinol
RxNorm CUI
15080

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Treatment of Lentigines: A Systematic Review.
Mukovozov Ilya, Roesler Jordanna, Kashetsky Nadia et al. · Dermatol Surg · 2023
PMID: 36533790Meta-Analysis
Reflectance confocal microscopy terminology glossary for nonmelanocytic skin lesions: A systematic review.
Navarrete-Dechent Cristian, DeRosa Antonio P, Longo Caterina et al. · J Am Acad Dermatol · 2019
PMID: 30529706Meta-AnalysisFull text (PMC)
Efficacy of isobutylamido thiazolyl resorcinol for prevention of laser-induced post-inflammatory hyperpigmentation: A randomized, controlled trial.
Vachiramon Vasanop, Sakpuwadol Nawara, Yongpisarn Tanat et al. · J Cosmet Dermatol · 2024
PMID: 38497328RCT
The clinical and electron microscopic evaluation of the impact of pulsed dye laser techniques on solar lentigines (randomized clinical trial).
Abd El-Naby Naeim, Mostafa Ali Mai, Hawwam Soha Abdalla et al. · J Dermatolog Treat · 2022
PMID: 32281430RCT
Safety and efficacy of combined use of 4-hydroxyanisole (mequinol) 2%/tretinoin 0.01% solution and sunscreen in solar lentigines.
Ortonne Jean Paul, Camacho Francisco, Wainwright Nicholas et al. · Cutis · 2004
PMID: 15551721Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Mequinol (substance)
SNOMED CT
422343004
UMLS CUI
C0048318
RxNorm CUI
15080

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.